LRRC8A proteins were elevated during the chronic exposure to oxaliplatin, but it's not yet distinguished if the changed LRRC8A was an accompanied or indispensable event in the process of acquiring resistance to oxaliplatin in colon cancer cells. Here, LRRC8A is linked to malignant colon neoplasm.